The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Skin and subcutaneous tissue disorders (SSTDs) in patients (pts) with HER2-positive metastatic breast cancer (MBC) in the phase III trial CLEOPATRA of pertuzumab or placebo with trastuzumab and docetaxel.
 
David Miles
Consulting or Advisory Role - Roche/Genentech
 
Andrea Lacasia
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Luen Lee
Employment - Roche/Genentech
Stock and Other Ownership Interests - Novartis; Roche Pharma AG
 
Kenneth Dana
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Consulting or Advisory Role - Roche/Genentech
 
Sarah Heeson
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Adam Knott
Employment - Roche Pharma AG
 
Chia C. Portera
Employment - Roche/Genentech
 
Sandra M. Swain
Honoraria - Clinigen Group; Roche
Consulting or Advisory Role - Clinigen Group; Genentech/Roche; OncoPlex Diagnostics
Research Funding - Genentech (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genentech (I); Genentech/Roche